Market Cap

Benchmark Botanics, Inc. Market Capitalization:

C$0

CAD as of Oct. 1, 2021

US$0

business Benchmark Botanics, Inc. Company Profile

Benchmark Botanics, Inc. Main Stock Listing

CSE: BBT

Market Capitalization History of Benchmark Botanics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Benchmark Botanics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2021 C$0

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

Benchmark Botanics, Inc. Categories

Canada languages Healthcare languages Drug Manufacturers—Specialty & Generic
Canada Healthcare Canada Drug Manufacturers—Specialty & Generic

Stocks & Indices

Benchmark Botanics, Inc. has the following listings and related stock indices.


Stock: CSE: BBT

Stock: OTC: BHHKF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.